AstraZeneca braced for hostile bid from Pfizer

Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its €76bn takeover offer was spurned.
The UK company said the offer “substantially” undervalued the business, forcing Pfizer to consider its next move.